Global Prostate Cancer Chemotherapy Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Page: 123
Published Date: 05 Sep 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Prostate Cancer Chemotherapy Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
The most common chemotherapy drug for prostate cancer is docetaxel (Taxotere), which is usually given with prednisone, a steroid medicine. After starting docetaxel, many men experience the improvements in disease-related symptoms, including pain, fatigue and loss of energy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Prostate Cancer Chemotherapy Drugs industry chain, the market status of Hospital Pharmacy (Abiraterone Acetate, Apalutamide), Retail Pharmacy (Abiraterone Acetate, Apalutamide), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Prostate Cancer Chemotherapy Drugs.
Regionally, the report analyzes the Prostate Cancer Chemotherapy Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Prostate Cancer Chemotherapy Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Prostate Cancer Chemotherapy Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Prostate Cancer Chemotherapy Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Abiraterone Acetate, Apalutamide).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Prostate Cancer Chemotherapy Drugs market.
Regional Analysis: The report involves examining the Prostate Cancer Chemotherapy Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Prostate Cancer Chemotherapy Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Prostate Cancer Chemotherapy Drugs:
Company Analysis: Report covers individual Prostate Cancer Chemotherapy Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Prostate Cancer Chemotherapy Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacy, Retail Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Prostate Cancer Chemotherapy Drugs. It assesses the current state, advancements, and potential future developments in Prostate Cancer Chemotherapy Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Prostate Cancer Chemotherapy Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Prostate Cancer Chemotherapy Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Abiraterone Acetate
Apalutamide
Bicalutamide
Cabazitaxel
Others
Market segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Sales
Other
Major players covered
Johnson & Johnson
Pfizer
Roche
Novartis
AbbVie
Bristol-Myer
Sanofi
AstraZeneca
Merck
Amgen
Bayer AG
Ipsen Group
Endo Pharmaceuticals
Dendreon Corporation
Myovant Biosciences
Effector Therapeutics
Mediolanum
ESSA Pharma
Astellas Pharma
Janssen
Eli Lilly and Company
POINT Biopharma
Hinnova Pharmaceuticals
Sophiris Bio
Ultimovacs
Foresee Pharmaceuticals
Luye Pharma Group
Abbott
Jiangsu HengRui Medicine
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostate Cancer Chemotherapy Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prostate Cancer Chemotherapy Drugs, with price, sales, revenue and global market share of Prostate Cancer Chemotherapy Drugs from 2018 to 2023.
Chapter 3, the Prostate Cancer Chemotherapy Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostate Cancer Chemotherapy Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Prostate Cancer Chemotherapy Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prostate Cancer Chemotherapy Drugs.
Chapter 14 and 15, to describe Prostate Cancer Chemotherapy Drugs sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Prostate Cancer Chemotherapy Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Prostate Cancer Chemotherapy Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Abiraterone Acetate
1.3.3 Apalutamide
1.3.4 Bicalutamide
1.3.5 Cabazitaxel
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Prostate Cancer Chemotherapy Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacy
1.4.3 Retail Pharmacy
1.4.4 Online Sales
1.4.5 Other
1.5 Global Prostate Cancer Chemotherapy Drugs Market Size & Forecast
1.5.1 Global Prostate Cancer Chemotherapy Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Prostate Cancer Chemotherapy Drugs Sales Quantity (2018-2029)
1.5.3 Global Prostate Cancer Chemotherapy Drugs Average Price (2018-2029)
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Prostate Cancer Chemotherapy Drugs Product and Services
2.1.4 Johnson & Johnson Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Johnson & Johnson Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Prostate Cancer Chemotherapy Drugs Product and Services
2.2.4 Pfizer Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Recent Developments/Updates
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Prostate Cancer Chemotherapy Drugs Product and Services
2.3.4 Roche Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Roche Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Prostate Cancer Chemotherapy Drugs Product and Services
2.4.4 Novartis Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments/Updates
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business
2.5.3 AbbVie Prostate Cancer Chemotherapy Drugs Product and Services
2.5.4 AbbVie Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AbbVie Recent Developments/Updates
2.6 Bristol-Myer
2.6.1 Bristol-Myer Details
2.6.2 Bristol-Myer Major Business
2.6.3 Bristol-Myer Prostate Cancer Chemotherapy Drugs Product and Services
2.6.4 Bristol-Myer Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bristol-Myer Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Prostate Cancer Chemotherapy Drugs Product and Services
2.7.4 Sanofi Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sanofi Recent Developments/Updates
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Prostate Cancer Chemotherapy Drugs Product and Services
2.8.4 AstraZeneca Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AstraZeneca Recent Developments/Updates
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Prostate Cancer Chemotherapy Drugs Product and Services
2.9.4 Merck Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Merck Recent Developments/Updates
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Prostate Cancer Chemotherapy Drugs Product and Services
2.10.4 Amgen Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Amgen Recent Developments/Updates
2.11 Bayer AG
2.11.1 Bayer AG Details
2.11.2 Bayer AG Major Business
2.11.3 Bayer AG Prostate Cancer Chemotherapy Drugs Product and Services
2.11.4 Bayer AG Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Bayer AG Recent Developments/Updates
2.12 Ipsen Group
2.12.1 Ipsen Group Details
2.12.2 Ipsen Group Major Business
2.12.3 Ipsen Group Prostate Cancer Chemotherapy Drugs Product and Services
2.12.4 Ipsen Group Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Ipsen Group Recent Developments/Updates
2.13 Endo Pharmaceuticals
2.13.1 Endo Pharmaceuticals Details
2.13.2 Endo Pharmaceuticals Major Business
2.13.3 Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product and Services
2.13.4 Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Endo Pharmaceuticals Recent Developments/Updates
2.14 Dendreon Corporation
2.14.1 Dendreon Corporation Details
2.14.2 Dendreon Corporation Major Business
2.14.3 Dendreon Corporation Prostate Cancer Chemotherapy Drugs Product and Services
2.14.4 Dendreon Corporation Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Dendreon Corporation Recent Developments/Updates
2.15 Myovant Biosciences
2.15.1 Myovant Biosciences Details
2.15.2 Myovant Biosciences Major Business
2.15.3 Myovant Biosciences Prostate Cancer Chemotherapy Drugs Product and Services
2.15.4 Myovant Biosciences Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Myovant Biosciences Recent Developments/Updates
2.16 Effector Therapeutics
2.16.1 Effector Therapeutics Details
2.16.2 Effector Therapeutics Major Business
2.16.3 Effector Therapeutics Prostate Cancer Chemotherapy Drugs Product and Services
2.16.4 Effector Therapeutics Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Effector Therapeutics Recent Developments/Updates
2.17 Mediolanum
2.17.1 Mediolanum Details
2.17.2 Mediolanum Major Business
2.17.3 Mediolanum Prostate Cancer Chemotherapy Drugs Product and Services
2.17.4 Mediolanum Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Mediolanum Recent Developments/Updates
2.18 ESSA Pharma
2.18.1 ESSA Pharma Details
2.18.2 ESSA Pharma Major Business
2.18.3 ESSA Pharma Prostate Cancer Chemotherapy Drugs Product and Services
2.18.4 ESSA Pharma Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 ESSA Pharma Recent Developments/Updates
2.19 Astellas Pharma
2.19.1 Astellas Pharma Details
2.19.2 Astellas Pharma Major Business
2.19.3 Astellas Pharma Prostate Cancer Chemotherapy Drugs Product and Services
2.19.4 Astellas Pharma Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Astellas Pharma Recent Developments/Updates
2.20 Janssen
2.20.1 Janssen Details
2.20.2 Janssen Major Business
2.20.3 Janssen Prostate Cancer Chemotherapy Drugs Product and Services
2.20.4 Janssen Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Janssen Recent Developments/Updates
2.21 Eli Lilly and Company
2.21.1 Eli Lilly and Company Details
2.21.2 Eli Lilly and Company Major Business
2.21.3 Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Product and Services
2.21.4 Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Eli Lilly and Company Recent Developments/Updates
2.22 POINT Biopharma
2.22.1 POINT Biopharma Details
2.22.2 POINT Biopharma Major Business
2.22.3 POINT Biopharma Prostate Cancer Chemotherapy Drugs Product and Services
2.22.4 POINT Biopharma Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 POINT Biopharma Recent Developments/Updates
2.23 Hinnova Pharmaceuticals
2.23.1 Hinnova Pharmaceuticals Details
2.23.2 Hinnova Pharmaceuticals Major Business
2.23.3 Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product and Services
2.23.4 Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Hinnova Pharmaceuticals Recent Developments/Updates
2.24 Sophiris Bio
2.24.1 Sophiris Bio Details
2.24.2 Sophiris Bio Major Business
2.24.3 Sophiris Bio Prostate Cancer Chemotherapy Drugs Product and Services
2.24.4 Sophiris Bio Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Sophiris Bio Recent Developments/Updates
2.25 Ultimovacs
2.25.1 Ultimovacs Details
2.25.2 Ultimovacs Major Business
2.25.3 Ultimovacs Prostate Cancer Chemotherapy Drugs Product and Services
2.25.4 Ultimovacs Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Ultimovacs Recent Developments/Updates
2.26 Foresee Pharmaceuticals
2.26.1 Foresee Pharmaceuticals Details
2.26.2 Foresee Pharmaceuticals Major Business
2.26.3 Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product and Services
2.26.4 Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Foresee Pharmaceuticals Recent Developments/Updates
2.27 Luye Pharma Group
2.27.1 Luye Pharma Group Details
2.27.2 Luye Pharma Group Major Business
2.27.3 Luye Pharma Group Prostate Cancer Chemotherapy Drugs Product and Services
2.27.4 Luye Pharma Group Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.27.5 Luye Pharma Group Recent Developments/Updates
2.28 Abbott
2.28.1 Abbott Details
2.28.2 Abbott Major Business
2.28.3 Abbott Prostate Cancer Chemotherapy Drugs Product and Services
2.28.4 Abbott Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.28.5 Abbott Recent Developments/Updates
2.29 Jiangsu HengRui Medicine
2.29.1 Jiangsu HengRui Medicine Details
2.29.2 Jiangsu HengRui Medicine Major Business
2.29.3 Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Product and Services
2.29.4 Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.29.5 Jiangsu HengRui Medicine Recent Developments/Updates
3.1 Global Prostate Cancer Chemotherapy Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Prostate Cancer Chemotherapy Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Prostate Cancer Chemotherapy Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Prostate Cancer Chemotherapy Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Prostate Cancer Chemotherapy Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Prostate Cancer Chemotherapy Drugs Manufacturer Market Share in 2022
3.5 Prostate Cancer Chemotherapy Drugs Market: Overall Company Footprint Analysis
3.5.1 Prostate Cancer Chemotherapy Drugs Market: Region Footprint
3.5.2 Prostate Cancer Chemotherapy Drugs Market: Company Product Type Footprint
3.5.3 Prostate Cancer Chemotherapy Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Prostate Cancer Chemotherapy Drugs Market Size by Region
4.1.1 Global Prostate Cancer Chemotherapy Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Prostate Cancer Chemotherapy Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Prostate Cancer Chemotherapy Drugs Average Price by Region (2018-2029)
4.2 North America Prostate Cancer Chemotherapy Drugs Consumption Value (2018-2029)
4.3 Europe Prostate Cancer Chemotherapy Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Prostate Cancer Chemotherapy Drugs Consumption Value (2018-2029)
4.5 South America Prostate Cancer Chemotherapy Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Prostate Cancer Chemotherapy Drugs Consumption Value (2018-2029)
5.1 Global Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2018-2029)
5.2 Global Prostate Cancer Chemotherapy Drugs Consumption Value by Type (2018-2029)
5.3 Global Prostate Cancer Chemotherapy Drugs Average Price by Type (2018-2029)
6.1 Global Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2018-2029)
6.2 Global Prostate Cancer Chemotherapy Drugs Consumption Value by Application (2018-2029)
6.3 Global Prostate Cancer Chemotherapy Drugs Average Price by Application (2018-2029)
7.1 North America Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2018-2029)
7.2 North America Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2018-2029)
7.3 North America Prostate Cancer Chemotherapy Drugs Market Size by Country
7.3.1 North America Prostate Cancer Chemotherapy Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Prostate Cancer Chemotherapy Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8.1 Europe Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Prostate Cancer Chemotherapy Drugs Market Size by Country
8.3.1 Europe Prostate Cancer Chemotherapy Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Prostate Cancer Chemotherapy Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9.1 Asia-Pacific Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Prostate Cancer Chemotherapy Drugs Market Size by Region
9.3.1 Asia-Pacific Prostate Cancer Chemotherapy Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Prostate Cancer Chemotherapy Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10.1 South America Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2018-2029)
10.2 South America Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2018-2029)
10.3 South America Prostate Cancer Chemotherapy Drugs Market Size by Country
10.3.1 South America Prostate Cancer Chemotherapy Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Prostate Cancer Chemotherapy Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11.1 Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Prostate Cancer Chemotherapy Drugs Market Size by Country
11.3.1 Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Prostate Cancer Chemotherapy Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12.1 Prostate Cancer Chemotherapy Drugs Market Drivers
12.2 Prostate Cancer Chemotherapy Drugs Market Restraints
12.3 Prostate Cancer Chemotherapy Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Prostate Cancer Chemotherapy Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Prostate Cancer Chemotherapy Drugs
13.3 Prostate Cancer Chemotherapy Drugs Production Process
13.4 Prostate Cancer Chemotherapy Drugs Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Prostate Cancer Chemotherapy Drugs Typical Distributors
14.3 Prostate Cancer Chemotherapy Drugs Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Prostate Cancer Chemotherapy Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Prostate Cancer Chemotherapy Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson Major Business
Table 5. Johnson & Johnson Prostate Cancer Chemotherapy Drugs Product and Services
Table 6. Johnson & Johnson Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Johnson & Johnson Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Prostate Cancer Chemotherapy Drugs Product and Services
Table 11. Pfizer Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer Recent Developments/Updates
Table 13. Roche Basic Information, Manufacturing Base and Competitors
Table 14. Roche Major Business
Table 15. Roche Prostate Cancer Chemotherapy Drugs Product and Services
Table 16. Roche Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Roche Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Prostate Cancer Chemotherapy Drugs Product and Services
Table 21. Novartis Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novartis Recent Developments/Updates
Table 23. AbbVie Basic Information, Manufacturing Base and Competitors
Table 24. AbbVie Major Business
Table 25. AbbVie Prostate Cancer Chemotherapy Drugs Product and Services
Table 26. AbbVie Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AbbVie Recent Developments/Updates
Table 28. Bristol-Myer Basic Information, Manufacturing Base and Competitors
Table 29. Bristol-Myer Major Business
Table 30. Bristol-Myer Prostate Cancer Chemotherapy Drugs Product and Services
Table 31. Bristol-Myer Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bristol-Myer Recent Developments/Updates
Table 33. Sanofi Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi Major Business
Table 35. Sanofi Prostate Cancer Chemotherapy Drugs Product and Services
Table 36. Sanofi Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sanofi Recent Developments/Updates
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Major Business
Table 40. AstraZeneca Prostate Cancer Chemotherapy Drugs Product and Services
Table 41. AstraZeneca Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. AstraZeneca Recent Developments/Updates
Table 43. Merck Basic Information, Manufacturing Base and Competitors
Table 44. Merck Major Business
Table 45. Merck Prostate Cancer Chemotherapy Drugs Product and Services
Table 46. Merck Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Merck Recent Developments/Updates
Table 48. Amgen Basic Information, Manufacturing Base and Competitors
Table 49. Amgen Major Business
Table 50. Amgen Prostate Cancer Chemotherapy Drugs Product and Services
Table 51. Amgen Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Amgen Recent Developments/Updates
Table 53. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 54. Bayer AG Major Business
Table 55. Bayer AG Prostate Cancer Chemotherapy Drugs Product and Services
Table 56. Bayer AG Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Bayer AG Recent Developments/Updates
Table 58. Ipsen Group Basic Information, Manufacturing Base and Competitors
Table 59. Ipsen Group Major Business
Table 60. Ipsen Group Prostate Cancer Chemotherapy Drugs Product and Services
Table 61. Ipsen Group Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Ipsen Group Recent Developments/Updates
Table 63. Endo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Endo Pharmaceuticals Major Business
Table 65. Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product and Services
Table 66. Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Endo Pharmaceuticals Recent Developments/Updates
Table 68. Dendreon Corporation Basic Information, Manufacturing Base and Competitors
Table 69. Dendreon Corporation Major Business
Table 70. Dendreon Corporation Prostate Cancer Chemotherapy Drugs Product and Services
Table 71. Dendreon Corporation Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Dendreon Corporation Recent Developments/Updates
Table 73. Myovant Biosciences Basic Information, Manufacturing Base and Competitors
Table 74. Myovant Biosciences Major Business
Table 75. Myovant Biosciences Prostate Cancer Chemotherapy Drugs Product and Services
Table 76. Myovant Biosciences Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Myovant Biosciences Recent Developments/Updates
Table 78. Effector Therapeutics Basic Information, Manufacturing Base and Competitors
Table 79. Effector Therapeutics Major Business
Table 80. Effector Therapeutics Prostate Cancer Chemotherapy Drugs Product and Services
Table 81. Effector Therapeutics Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Effector Therapeutics Recent Developments/Updates
Table 83. Mediolanum Basic Information, Manufacturing Base and Competitors
Table 84. Mediolanum Major Business
Table 85. Mediolanum Prostate Cancer Chemotherapy Drugs Product and Services
Table 86. Mediolanum Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Mediolanum Recent Developments/Updates
Table 88. ESSA Pharma Basic Information, Manufacturing Base and Competitors
Table 89. ESSA Pharma Major Business
Table 90. ESSA Pharma Prostate Cancer Chemotherapy Drugs Product and Services
Table 91. ESSA Pharma Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. ESSA Pharma Recent Developments/Updates
Table 93. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 94. Astellas Pharma Major Business
Table 95. Astellas Pharma Prostate Cancer Chemotherapy Drugs Product and Services
Table 96. Astellas Pharma Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Astellas Pharma Recent Developments/Updates
Table 98. Janssen Basic Information, Manufacturing Base and Competitors
Table 99. Janssen Major Business
Table 100. Janssen Prostate Cancer Chemotherapy Drugs Product and Services
Table 101. Janssen Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Janssen Recent Developments/Updates
Table 103. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 104. Eli Lilly and Company Major Business
Table 105. Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Product and Services
Table 106. Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Eli Lilly and Company Recent Developments/Updates
Table 108. POINT Biopharma Basic Information, Manufacturing Base and Competitors
Table 109. POINT Biopharma Major Business
Table 110. POINT Biopharma Prostate Cancer Chemotherapy Drugs Product and Services
Table 111. POINT Biopharma Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. POINT Biopharma Recent Developments/Updates
Table 113. Hinnova Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 114. Hinnova Pharmaceuticals Major Business
Table 115. Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product and Services
Table 116. Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 117. Hinnova Pharmaceuticals Recent Developments/Updates
Table 118. Sophiris Bio Basic Information, Manufacturing Base and Competitors
Table 119. Sophiris Bio Major Business
Table 120. Sophiris Bio Prostate Cancer Chemotherapy Drugs Product and Services
Table 121. Sophiris Bio Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 122. Sophiris Bio Recent Developments/Updates
Table 123. Ultimovacs Basic Information, Manufacturing Base and Competitors
Table 124. Ultimovacs Major Business
Table 125. Ultimovacs Prostate Cancer Chemotherapy Drugs Product and Services
Table 126. Ultimovacs Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 127. Ultimovacs Recent Developments/Updates
Table 128. Foresee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 129. Foresee Pharmaceuticals Major Business
Table 130. Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product and Services
Table 131. Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 132. Foresee Pharmaceuticals Recent Developments/Updates
Table 133. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 134. Luye Pharma Group Major Business
Table 135. Luye Pharma Group Prostate Cancer Chemotherapy Drugs Product and Services
Table 136. Luye Pharma Group Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Luye Pharma Group Recent Developments/Updates
Table 138. Abbott Basic Information, Manufacturing Base and Competitors
Table 139. Abbott Major Business
Table 140. Abbott Prostate Cancer Chemotherapy Drugs Product and Services
Table 141. Abbott Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Abbott Recent Developments/Updates
Table 143. Jiangsu HengRui Medicine Basic Information, Manufacturing Base and Competitors
Table 144. Jiangsu HengRui MedicineMajor Business
Table 145. Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Product and Services
Table 146. Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 147. Jiangsu HengRui Medicine Recent Developments/Updates
Table 148. Global Prostate Cancer Chemotherapy Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 149. Global Prostate Cancer Chemotherapy Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 150. Global Prostate Cancer Chemotherapy Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 151. Market Position of Manufacturers in Prostate Cancer Chemotherapy Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 152. Head Office and Prostate Cancer Chemotherapy Drugs Production Site of Key Manufacturer
Table 153. Prostate Cancer Chemotherapy Drugs Market: Company Product Type Footprint
Table 154. Prostate Cancer Chemotherapy Drugs Market: Company Product Application Footprint
Table 155. Prostate Cancer Chemotherapy Drugs New Market Entrants and Barriers to Market Entry
Table 156. Prostate Cancer Chemotherapy Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 157. Global Prostate Cancer Chemotherapy Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 158. Global Prostate Cancer Chemotherapy Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 159. Global Prostate Cancer Chemotherapy Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 160. Global Prostate Cancer Chemotherapy Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 161. Global Prostate Cancer Chemotherapy Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 162. Global Prostate Cancer Chemotherapy Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 163. Global Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 164. Global Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 165. Global Prostate Cancer Chemotherapy Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 166. Global Prostate Cancer Chemotherapy Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 167. Global Prostate Cancer Chemotherapy Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 168. Global Prostate Cancer Chemotherapy Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 169. Global Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 170. Global Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 171. Global Prostate Cancer Chemotherapy Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 172. Global Prostate Cancer Chemotherapy Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 173. Global Prostate Cancer Chemotherapy Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 174. Global Prostate Cancer Chemotherapy Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 175. North America Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 176. North America Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 177. North America Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 178. North America Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 179. North America Prostate Cancer Chemotherapy Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 180. North America Prostate Cancer Chemotherapy Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 181. North America Prostate Cancer Chemotherapy Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 182. North America Prostate Cancer Chemotherapy Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 183. Europe Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 184. Europe Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 185. Europe Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 186. Europe Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 187. Europe Prostate Cancer Chemotherapy Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 188. Europe Prostate Cancer Chemotherapy Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 189. Europe Prostate Cancer Chemotherapy Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 190. Europe Prostate Cancer Chemotherapy Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 191. Asia-Pacific Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 192. Asia-Pacific Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 193. Asia-Pacific Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 194. Asia-Pacific Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 195. Asia-Pacific Prostate Cancer Chemotherapy Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 196. Asia-Pacific Prostate Cancer Chemotherapy Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 197. Asia-Pacific Prostate Cancer Chemotherapy Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 198. Asia-Pacific Prostate Cancer Chemotherapy Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 199. South America Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 200. South America Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 201. South America Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 202. South America Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 203. South America Prostate Cancer Chemotherapy Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 204. South America Prostate Cancer Chemotherapy Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 205. South America Prostate Cancer Chemotherapy Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 206. South America Prostate Cancer Chemotherapy Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 207. Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 208. Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 209. Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 210. Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 211. Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 212. Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 213. Middle East & Africa Prostate Cancer Chemotherapy Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 214. Middle East & Africa Prostate Cancer Chemotherapy Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 215. Prostate Cancer Chemotherapy Drugs Raw Material
Table 216. Key Manufacturers of Prostate Cancer Chemotherapy Drugs Raw Materials
Table 217. Prostate Cancer Chemotherapy Drugs Typical Distributors
Table 218. Prostate Cancer Chemotherapy Drugs Typical Customers
List of Figures
Figure 1. Prostate Cancer Chemotherapy Drugs Picture
Figure 2. Global Prostate Cancer Chemotherapy Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Prostate Cancer Chemotherapy Drugs Consumption Value Market Share by Type in 2022
Figure 4. Abiraterone Acetate Examples
Figure 5. Apalutamide Examples
Figure 6. Bicalutamide Examples
Figure 7. Cabazitaxel Examples
Figure 8. Others Examples
Figure 9. Global Prostate Cancer Chemotherapy Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Prostate Cancer Chemotherapy Drugs Consumption Value Market Share by Application in 2022
Figure 11. Hospital Pharmacy Examples
Figure 12. Retail Pharmacy Examples
Figure 13. Online Sales Examples
Figure 14. Other Examples
Figure 15. Global Prostate Cancer Chemotherapy Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Prostate Cancer Chemotherapy Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Prostate Cancer Chemotherapy Drugs Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Prostate Cancer Chemotherapy Drugs Average Price (2018-2029) & (US$/Unit)
Figure 19. Global Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Prostate Cancer Chemotherapy Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Prostate Cancer Chemotherapy Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Prostate Cancer Chemotherapy Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Prostate Cancer Chemotherapy Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Prostate Cancer Chemotherapy Drugs Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Prostate Cancer Chemotherapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Prostate Cancer Chemotherapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Prostate Cancer Chemotherapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Prostate Cancer Chemotherapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Prostate Cancer Chemotherapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Prostate Cancer Chemotherapy Drugs Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Prostate Cancer Chemotherapy Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Prostate Cancer Chemotherapy Drugs Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Prostate Cancer Chemotherapy Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 37. North America Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Prostate Cancer Chemotherapy Drugs Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Prostate Cancer Chemotherapy Drugs Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Prostate Cancer Chemotherapy Drugs Consumption Value Market Share by Region (2018-2029)
Figure 57. China Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Prostate Cancer Chemotherapy Drugs Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Prostate Cancer Chemotherapy Drugs Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Prostate Cancer Chemotherapy Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Prostate Cancer Chemotherapy Drugs Market Drivers
Figure 78. Prostate Cancer Chemotherapy Drugs Market Restraints
Figure 79. Prostate Cancer Chemotherapy Drugs Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Prostate Cancer Chemotherapy Drugs in 2022
Figure 82. Manufacturing Process Analysis of Prostate Cancer Chemotherapy Drugs
Figure 83. Prostate Cancer Chemotherapy Drugs Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Johnson & Johnson Pfizer Roche Novartis AbbVie Bristol-Myer Sanofi AstraZeneca Merck Amgen Bayer AG Ipsen Group Endo Pharmaceuticals Dendreon Corporation Myovant Biosciences Effector Therapeutics Mediolanum ESSA Pharma Astellas Pharma Janssen Eli Lilly and Company POINT Biopharma Hinnova Pharmaceuticals Sophiris Bio Ultimovacs Foresee Pharmaceuticals Luye Pharma Group Abbott Jiangsu HengRui Medicine
Related Reports
19 May 2022
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
